AAAAAA
Results: 1-25/28
Authors:
Maeurer, MJ
Necker, A
Salter, RD
Castelli, C
Hohn, H
Karbach, J
Freitag, K
Neukirch, C
Knuth, A
Jager, E
Citation: Mj. Maeurer et al., Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue, INT J CANC, 97(1), 2002, pp. 64-71
Authors:
Jager, E
Jager, D
Knuth, A
Citation: E. Jager et al., Perspectives of tumour immunology: antigen-specific immunotherapy of malignant diseases, DEUT MED WO, 126(37), 2001, pp. 1011-1016
Authors:
Maeurer, M
Hohn, H
Castelli, C
Salter, RD
Necker, A
Reichert, T
Knuth, A
Jager, E
Citation: M. Maeurer et al., Antigen recognition by T cells: a strong sense of structure, TRENDS IMMU, 22(11), 2001, pp. 599-601
Authors:
Jager, D
Jager, E
Knuth, A
Citation: D. Jager et al., Targets for immunotherapy in breast cancer, BREAST, 10, 2001, pp. 23-26
Authors:
Jager, E
Jager, D
Knuth, A
Citation: E. Jager et al., Vaccines in breast cancer, BREAST, 10, 2001, pp. 158-160
Authors:
Westermann, AM
Grosen, EA
Katschinski, DM
Jager, D
Rietbroek, R
Schink, JC
Tiggelaar, CL
Jager, E
Vording, PZVS
Neuman, A
Knuth, A
Van Dijk, JDP
Wiedemann, GJ
Robins, HI
Citation: Am. Westermann et al., Pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer, EUR J CANC, 37(9), 2001, pp. 1111-1117
Authors:
Jager, D
Jagar, E
Knuth, A
Citation: D. Jager et al., Vaccination for malignant melanoma: Recent developments, ONCOL-BASEL, 60(1), 2001, pp. 1-7
Authors:
Jager, D
Jager, E
Knuth, A
Citation: D. Jager et al., Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer, J CLIN PATH, 54(9), 2001, pp. 669-674
Authors:
Jager, D
Stockert, E
Gure, AO
Scanlan, MJ
Karbach, J
Jager, E
Knuth, A
Old, LJ
Chen, YT
Citation: D. Jager et al., Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library, CANCER RES, 61(5), 2001, pp. 2055-2061
Authors:
von der Maase, H
Hansen, SW
Roberts, JT
Dogliotti, L
Oliver, T
Moore, MJ
Bodrogi, I
Albers, P
Knuth, A
Lippert, CM
Kerbrat, P
Rovira, PS
Wersall, P
Cleall, SP
Roychowdhury, DF
Tomlin, I
Visseren-Grul, CM
Conte, PF
Citation: H. Von Der Maase et al., Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study, J CL ONCOL, 18(17), 2000, pp. 3068-3077
Authors:
Jager, E
Jager, D
Knuth, A
Citation: E. Jager et al., Peptide vaccination in clinical oncology, ONKOLOGIE, 23(5), 2000, pp. 410-415
Authors:
Jager, E
Jager, D
Orth, J
Knuth, A
Citation: E. Jager et al., Irinotecan in second-line therapy of metastatic colorectal cancer, ONKOLOGIE, 23, 2000, pp. S15-S17
Authors:
Knuth, A
Jager, D
Jager, E
Citation: A. Knuth et al., Cancer immunotherapy in clinical oncology, CANC CHEMOT, 46, 2000, pp. S46-S51
Authors:
Jager, E
Nagata, Y
Gnjatic, S
Wada, H
Stockert, E
Karbach, J
Dunbar, PR
Lee, SY
Jungbluth, A
Jager, D
Arand, M
Ritter, C
Cerundolo, V
Dupont, B
Chen, YT
Old, LJ
Knuth, A
Citation: E. Jager et al., Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses, P NAS US, 97(9), 2000, pp. 4760-4765
Authors:
Jager, E
Gnjatic, S
Nagata, Y
Stockert, E
Jager, D
Karbach, J
Neumann, A
Rieckenberg, J
Chen, YT
Ritter, G
Hoffman, E
Arand, M
Old, LJ
Knuth, A
Citation: E. Jager et al., Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers, P NAS US, 97(22), 2000, pp. 12198-12203
Authors:
Gnjatic, S
Nagata, Y
Jager, E
Stockert, E
Shankara, S
Roberts, BL
Mazzara, GP
Lee, SY
Dunbar, PR
Dupont, B
Cerundolo, V
Ritter, G
Chen, YT
Knuth, A
Old, LJ
Citation: S. Gnjatic et al., Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele, P NAS US, 97(20), 2000, pp. 10917-10922
Authors:
Chen, JL
Dunbar, PR
Gileadi, U
Jager, E
Gnjatic, S
Nagata, Y
Stockert, E
Panicalli, DL
Chen, YT
Knuth, A
Old, LJ
Cerundolo, V
Citation: Jl. Chen et al., Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL, J IMMUNOL, 165(2), 2000, pp. 948-955
Authors:
Jager, E
Jager, D
Karbach, J
Chen, YT
Ritter, G
Nagata, Y
Gnjatic, S
Stockert, E
Arand, M
Old, LJ
Knuth, A
Citation: E. Jager et al., Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB40101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma, J EXP MED, 191(4), 2000, pp. 625-630
Authors:
Jager, E
Maeurer, M
Hohn, H
Karbach, J
Jager, D
Zidianakis, Z
Bakhshandeh-Bath, A
Orth, J
Neukirch, C
Necker, A
Reichert, TE
Knuth, A
Citation: E. Jager et al., Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanomapatient responding to continued immunization with melanoma-associated peptides, INT J CANC, 86(4), 2000, pp. 538-547
Authors:
Jager, D
Stockert, E
Jager, E
Gure, AO
Scanlan, MJ
Knuth, A
Old, LJ
Chen, YT
Citation: D. Jager et al., Serological cloning of a melanocyte rab guanosine 5 '-triphosphate-bindingprotein and a chromosome condensation protein from a melanoma complementary DNA library, CANCER RES, 60(13), 2000, pp. 3584-3591
Authors:
Jung, D
Hilmes, C
Knuth, A
Jaeger, E
Huber, C
Seliger, B
Citation: D. Jung et al., Gene transfer of the co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent, SC J IMMUN, 50(3), 1999, pp. 242-249
Authors:
Jager, E
Jager, D
Knuth, A
Citation: E. Jager et al., CTL-defined cancer vaccines: Perspectives for active immunotherapeutic interventions in minimal residual disease, CANC METAST, 18(1), 1999, pp. 143-150
Authors:
Jager, E
Stockert, E
Zidianakis, Z
Chen, YT
Karbach, J
Jager, D
Arand, M
Ritter, G
Old, LJ
Knuth, A
Citation: E. Jager et al., Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: Correlation with clinical events, INT J CANC, 84(5), 1999, pp. 506-510
Authors:
Scanlan, MJ
Gordan, JD
Williamson, B
Stockert, E
Bander, NH
Jongeneel, V
Gure, AO
Jager, D
Jager, E
Knuth, A
Chen, YT
Old, LJ
Citation: Mj. Scanlan et al., Antigens recognized by autologous antibody in patients with renal-cell carcinoma, INT J CANC, 83(4), 1999, pp. 456-464
Authors:
Jager, E
Hohn, H
Karbach, J
Momburg, F
Castelli, C
Knuth, A
Seliger, B
Maeurer, MJ
Citation: E. Jager et al., Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A, INT J CANC, 81(6), 1999, pp. 979-984